AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca
Read more
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca
Read moreAstraZeneca vaccine ‘safe and effective’ says EMA When you subscribe we will use the information you provide to send you
Read moreThe United States will deliver 1.5 million surplus doses of AstraZeneca’s coronavirus vaccine to Canada next week, Canadian Procurement Minister
Read moreFILE PHOTO: A person receives a dose of Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination centre in Antwerp, Belgium March 18,
Read moreAstraZeneca: Expert says suspension could 'dent confidence' When you subscribe we will use the information you provide to send you
Read morePortugal, following a number of other European countries, has approved AstraZeneca’s COVID-19 vaccine for people aged 65 and over, the
Read moreSwedish health authorities on Thursday recommended AstraZeneca’s COVID-19 vaccine for people over the age of 65, following in the footsteps
Read moreStaff member handles AstraZeneca COVID-19 vaccines in storage at Region Hovedstaden’s Vaccine Center, Copenhagen, Denmark February 11, 2021. Ritzau Scanpix/Liselotte
Read moreFILE PHOTO: The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease
Read moreBritain was on Monday set to begin a mass rollout of the Oxford-AstraZeneca coronavirus vaccine, the cheap and easy to
Read more